Levin Capital Strategies’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-35,000
Closed -$416K 183
2024
Q4
$416K Buy
+35,000
New +$597K 0.04% 142
2023
Q1
Sell
-5,000
Closed -$59K 248
2022
Q4
$59K Sell
5,000
-15,000
-75% -$171K 0.01% 224
2022
Q3
$184K Sell
20,000
-10,000
-33% -$121K 0.02% 185
2022
Q2
$296K Buy
30,000
+22,000
+275% +$444K 0.04% 175
2022
Q1
$276K Buy
+8,000
New +$260K 0.03% 221

Other funds holding ASPN

Levin Capital Strategies's ASPN Position: Q4 2023 in Review

Levin Capital Strategies sold out of Aspen Aerogels (ASPN) in Q4 2023, closing a stake of 70,613 shares — an estimated $607K sold.

Levin Capital Strategies first reported a position in ASPN in Q2 2022 and held it in 6 quarters. The position peaked at $607K in Q3 2023. 170 funds tracked by Wall St. Rank hold ASPN as of Q4 2023.

  • Levin Capital Strategies reported no remaining Aspen Aerogels position as of Q4 2023 after selling out during the quarter.
  • Levin Capital Strategies sold 70,613 Aspen Aerogels shares in Q4 2023, an estimated $607K.
  • Levin Capital Strategies first reported a position in Aspen Aerogels in Q2 2022 and held it in 6 quarters.
  • Levin Capital Strategies's Aspen Aerogels position peaked at $607K in Q3 2023.
  • 170 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2023.

Based on Levin Capital Strategies's 13F filing for Q4 2023, filed 6 Feb 2024.